Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OncoSec Medical Inc ONCSQ

Healthcare Biotechnology
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec... see more

Recent & Breaking News (GREY:ONCSQ)

OncoSec Medical To Relaunch Phase II Cutaneous T-Cell Lymphoma Study at Key Centers of Excellence

Business Wire April 7, 2014

OncoSec Medical to Present at Two Conferences in New York City in April

Business Wire March 31, 2014

OncoSec Medical to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum

Business Wire March 17, 2014

OncoSec Medical to Evaluate Increased Dose Frequency of ImmunoPulse in Ongoing Phase II Melanoma Trial

Business Wire March 12, 2014

MultiCell Technologies Seeks Patent for Cancer-Fighting Technology

Accesswire March 4, 2014

Fortitude Group Cuts Lucrative Deal to Process Debit Cards for Marijuana Purchases

Accesswire February 27, 2014

OncoSec Medical to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference

Business Wire February 25, 2014

OncoSec Medical to Present at 16th Annual BIO CEO & Investor Conference

Business Wire February 4, 2014

OncoSec Medical Announces 2014 Strategic Update

Business Wire January 14, 2014

OncoSec Medical to Present at "TEN"; Noble Financial Capital Markets' Tenth Annual Equity Conference

Business Wire January 13, 2014

OncoSec Medical to Present Corporate Update at Biotech Showcase 2014

Business Wire January 7, 2014

TrendingWallStreet.com Puts Out Market Reports on ANGI, YGE, ONCS, and GE

Accesswire January 3, 2014

TrendingWallStreet.com Initiates Trend Alerts on NVAX, JCP, NAMG, and ONCS

Accesswire December 24, 2013

TrendingWallStreet.com Initiates Analysis on PATH, ONCS, USU, and NNRX

Accesswire December 17, 2013

OncoSec Medical Announces Positive Interim Data from Phase 2 Study of OMS-I100 in Metastatic Melanoma

Business Wire December 16, 2013

OncoSec Medical Announces Hire of Chief Medical Officer

Business Wire December 12, 2013

OncoSec Medical to Present at the 6th Annual LD Micro Conference

Business Wire November 26, 2013

Exclusive Stock Reports on HIPP, QUAN and ONCS

Accesswire November 8, 2013

New In Depth Equity Reports on ONCS, DROP and MSLP

Accesswire October 28, 2013

New Equity Reports on ONCS, PVCT and HEMP

Accesswire October 24, 2013